Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in individuals aged 12 to 64 with at least one underlying ...

Sept 23 (Reuters) - Moderna (MRNA.O), opens new tab said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in ...

Moderna (NASDAQ:MRNA) updated data from a Phase 4 clinical trial for its redesigned COVID-19 vaccine, noting that the mRNA-based shot branded as mNEXSPIKE led to more than a 15-fold increase in ...

Amid uncertainty over how the Trump administration would approach mRNA COVID-19 vaccines for the upcoming respiratory virus season, the FDA has approved updated shots from Pfizer and Moderna. But ...

If you’ve been wondering, “When will the 2025 COVID vaccine be widely available?” you’re not alone. By this time last year, the 2024-25 COVID-19 vaccines had already been approved by the Food and Drug ...

The Food and Drug Administration (FDA) released a key report Tuesday that said a COVID-19 vaccine made by Moderna is safe and effective — the latest in a series of rubber stamp approvals that could ...

CHICAGO, Sept 29 (Reuters) - Results from an early safety study of Moderna Inc's (MRNA.O), opens new tab coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing ...

On December 18, a San Diego emergency room nurse was given a shot of the COVID-19 vaccine. A week later, he tested positive for the virus, CNN affiliate KGTV reported. Stories like this will become ...

CAMBRIDGE, Mass. — Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in individuals aged 12-64 with at ...